Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
January-2015 Volume 11 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2015 Volume 11 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Hepatic Nrf2 expression is altered by quercetin supplementation in X‑irradiated rats

  • Authors:
    • Raquel Marina
    • Paquita González
    • M. Carmen Ferreras
    • Serafín Costilla
    • Juan‑Pablo Barrio
  • View Affiliations / Copyright

    Affiliations: Universidad Autónoma de Chile, Santiago de Chile 7500566, Chile, Department of Biomedical Sciences, University of León, León 24071, Spain, Department of Animal Health, University of León, León 24071, Spain, Department of Medicine, University of Oviedo, Oviedo 33006, Spain
  • Pages: 539-546
    |
    Published online on: October 22, 2014
       https://doi.org/10.3892/mmr.2014.2741
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Whole‑body irradiation has been associated with liver function alterations. Ionizing radiation exposure increases oxidative stress and antioxidants can activate transcription of antioxidant target genes. In the present study, modifications of the liver antioxidant system were evaluated at 7 and 30 days following sub‑lethal whole‑body X‑irradiation in male Wistar rats, which were intragastrically supplemented with quercetin or control solvent for 4 days prior to and 6 days following irradiation. Animal groups were as follows: CS, control, solvent‑supplemented; CQ, control, quercetin‑supplemented; RS, irradiated, solvent‑supplemented; and RQ, irradiated, quercetin‑supplemented. After 7 days, liver tissue from RS animals demonstrated marked hydropic panlobular degeneration with Mallory bodies in ballooning hepatocytes. These changes were mostly reversed in RQ rats. Lipid peroxidation in addition to copper/zinc superoxide dismutase (Cu/Zn‑SOD), nuclear factor (erythroid‑derived 2)‑like 2 (Nrf2) and Kelch‑like ECH‑associated protein 1 (Keap1) protein expression levels were all increased by X‑irradiation, but significantly decreased by quercetin supplementation. Catalase (CAT) and NAD(P)H: quinone oxidoreductase 1 (NQO1) expression levels remained high in irradiated rats regardless of quercetin supplementation. After 30 days, the liver from RS animals had small portal infiltrates and diffuse cytoplasmic vacuolization, with reduced lipid peroxidation and reduced expression levels of CAT, NQO1, Nrf2 and Keap1, but consistently elevated Cu/Zn‑SOD expression. RQ animals indicated reduced expression levels of Nrf2 and Keap1 30 days after irradiation. The present study demonstrated a quercetin‑induced reduction of the oxidative stress‑associated increase in Nrf2 expression that may be useful for preventing cancer cell survival in response to ionizing radiation exposure.

Introduction

Polyphenols are antioxidant molecules that exist in a wide variety of fruits and vegetables. These compounds are able to interact with defense systems of the cell, and upregulate genes containing a cis-acting element in their promoter region known as antioxidant response element/electrophile response element (ARE/EpRE) (1). When oxidative stress occurs in the cells, nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is released from the cytoplasm and translocates to the nucleus. Nrf2 binds the ARE in the regulatory regions of antioxidant target genes and activates transcription, which ultimately provides protection against a number of pathologies in various organs, including the liver, intestines, lungs, skin and nervous system (2).

Quercetin is one of the most frequently consumed dietary flavonoids, and serves multiple biologically significant functions, including antioxidant, anti-carcinogenic, anti-inflammatory, cardioprotective and radioprotective properties (3–5). Quercetin is able to affect the ARE activation pathway, and molecular studies have indicated the upregulation of Nrf2 through the regulation of both transcriptional and post-transcriptional sites of Nrf2. Enhanced repression of Kelch-like ECH-associated protein 1 (Keap1) was also demonstrated by affecting the post-transcriptional site, which revealed a number of substantial differences between oxidative inducers (1).

A plethora of studies associating antioxidant properties with the ability to reduce cytotoxic effects of ionizing radiation have been conducted. Healthy tissues can be damaged in multiple ways by radiation, depending on the type of cells and organs being irradiated, the dose and dose rate of radiation exposure, and the time elapsed from radiation exposure to the study of the effects. Chronic, low dose exposure to ionizing radiation can result in the induction of antioxidant enzymes, but not in a dose-dependent way. Otsuka et al (6) demonstrated that exposure of mice to 0.5 Gy at a dose rate of 1.2 mGy/h for 23 days increased the gene expression of catalase and MnSOD by a factor of 2.5, while at higher doses of 1.0 and 1.3 Gy at a similar dose rate, gene expression either increased by only 1.4 or was not significantly different from non-irradiated controls, respectively.

The nucleus, cell membrane and mitochondria are considered sensitive targets for the reduction or prevention of radiation damage by antioxidants (7). One of the most studied effects of ionizing radiation is DNA damage. In order to exert preventive effects on the immediate genotoxicity induced by ionizing radiation, antioxidants must be able to access the nucleus and be near the DNA strands at the time of irradiation. Antioxidant agents may act via the scavenging of oxygen-based free radicals in addition to competing with oxygen for chemically repairing DNA damage by reacting with free radicals on the DNA (7). When ionizing radiation impacts on lipid membranes, the resulting increase in the formation of lipid radicals and peroxides can cause damage or the release of membrane proteins, or it can promote the liberation of lipid-based peroxidation products that will react with other cell structures (8). Long-term cell survival requires the availability of sufficient functional mitochondria to meet energy needs, and these organelles are particularly well-suited to withstand radiation damage due to their high antioxidant capacity and the fact that their DNA is located in multiple replicates (9).

Whole-body irradiation has been used in the clinical treatment of malignancies to induce immunosuppression and prevent allograft rejection, and it has been associated with significant changes in liver function (10). The aim of the present study was to evaluate the modifications in the liver antioxidant system by X-irradiation in male Wistar rats under whole-body irradiation with a single sub-lethal dose, and the effects of quercetin supplementation prior to and following irradiation. The assessment was performed at 7 and 30 days following irradiation.

Materials and methods

Animals

Male Wistar rats (250 g), were initially housed in a room maintained at 22°C with a relative humidity ranging from 45 to 55% and a 12-h dark/light cycle. The animals had free access to food (standard diet from Panlab, Barcelona, Spain) and water, and were not starved prior to experiments. All study protocols were reviewed and approved by the University of León Animal Care Committee (León, Spain) and were in accordance with the indications of the current Spanish and European laws (RD 53/2013 and EU Directive 2010/63/EU).

Experimental procedures

Animals were split into four groups of 8, based on irradiation (non-irradiated controls and X-ray exposure group) and time periods of analysis (7 and 30 days). On the assumption that quercetin may have radiomitigative effects shortly following irradiation exposure (11), intragastric quercetin supplementation (50 mg/kg body weight) was used, following a previous study by Kawai et al (12). Thus, quercetin (50 mg/kg body weight in propylene glycol) was administered intragastrically for 4 days prior to and 6 days following irradiation, and non-supplemented animals received the same volume of propylene glycol solvent alone. The groups were then constituted as the CS (controls, solvent-supplemented), CQ (controls, quercetin-supplemented), RS (irradiated, solvent-supplemented) and RQ (irradiated, quercetin-supplemented) groups.

Experimental irradiation with X-rays

RS and RQ animals were whole-body irradiated with a single X-ray dose of 6 Gy administered over 15 min, at a source-skin distance of 50 cm. In order to immobilize the animals, anesthesia was induced by intraperitoneal administration of pentobarbital 0.5% in saline (10 ml/kg body weight) at noon. This was 15 min prior to irradiation in order to ensure the loss of palpebral and plantar reflex activity, and spontaneous respiration throughout the procedure. The animals were positioned decubitus pronus on a plexiglas board, so that two animals were irradiated simultaneously. CS and CQ animals underwent the same procedure, excluding irradiation. The X-ray source was a Maxishot 200 (YXLON International GmbH, Hamburg, Germany) operated by qualified staff at the Instrumental Techniques Laboratory, University of León, in accordance with current Spanish legislation on radiation equipment use. X-ray filtration was accomplished in the Maxishot 200 machine according to manufacturer’s instructions using 4-mm thick beryllium and 3-mm thick aluminum filters in the X-ray tube unit. Uniform total-body X-irradiation distribution was confirmed by dosimetry using isodose curves for measurement. A test with a phantom (water layer) was performed in order to check self-shielding without changes in the dose distribution profile for the thickness involved.

Determination of lipid peroxidation

Aldehydic products generated by lipid peroxidation were determined by the thiobarbituric acid (TBA) reaction with malondialdehyde using the methods of a previous study (13). Liver (1 g) was homogenated in 9 ml potassium phosphate (0.1 M, pH 7.4) and tubes were prepared with 1 ml fresh homogenate plus 2 ml of a solution containing 15% trichloroacetic acid, 0.37% TBA, and 0.25 M HCl. After 30 min at 90°C, the tubes were cooled and centrifuged at 2,000 × g. Supernatants were collected and their absorbance read at 532 nm.

Protein expression of copper/zinc superoxide dismutase (Cu/Zn-SOD), catalase (CAT), NAD(P)H: quinone oxidoreductase 1 (NQO1), Nrf2 and Keap1

Liver tissue was cut into small pieces and homogenized in RIPA buffer [Tris-HCl 50 mM pH 7.4, KCl 150 mM, sodium deoxycholate 0.5%, NP-40 0.1% and sodium dodecyl sulfate (SDS) 0.1%] with protease/phosphatase cocktail (one tablet per 10 ml RIPA buffer) (Roche Farma S.A., Madrid, Spain).

The cytoplasmic fraction was obtained as the supernatant from centrifugation of the liver extract (1 h, 4°C, 12,000 × g). The nuclear fraction was obtained from fresh liver tissue, homogenized in buffer A (10 mM HEPES-NaOH pH 7.9, 1.5 mM MgCl2 and 10 mM KCl) including 0.1% NP-40 (EMD Millipore, Billerica, MA, USA) and centrifuged (10 min, 4°C, 1,000 × g). The pellet was resuspended in buffer A without NP-40, centrifuged again, and then resuspended again in buffer B (20 mM HEPES-NaOH pH 7.9, glycerol, 420 mM NaCl, 1.5 mM MgCl2 and 0.2 mM EDTA pH 8.0), prior to being centrifuged for 30 min at 4°C and 12,000 × g.

Samples containing 50–100 μg protein were separated by SDS-polyacrylamide gel electrophoresis (12–14% acrylamide) and transferred onto polyvinylidine fluoride membranes (EMD Millipore). The membranes were subsequently immersed in Ponceau stain in order to verify equal sample loading. Non-specific binding was blocked by pre-incubation of the membranes in phosphate-buffered saline containing 3–5% non-fat dried milk for 30 min at 37°C. Membranes were then incubated overnight at 4°C with polyclonal anti-Cu/Zn-SOD, anti-CAT, anti-NQO1, anti-Nrf2 and anti-Keap1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Bound primary antibody was detected using a horseradish peroxidase-conjugated goat anti-mouse antibody (Dako, Glostrup, Denmark) by chemiluminescence using an Amersham ECL kit (GE Healthcare, Chalfont, UK) according to the manufacturer’s instructions.

Histology

For histopathological examination, samples of the liver were trimmed and fixed by immersion in 10% buffered formalin for 24 h. The blocks were dehydrated in a graded series of ethanol solutions (50, 70, 96 and 100%) and embedded in paraffin wax. Serial 4-μm sections were stained with hematoxylin and eosin and evaluated blindly by a pathologist. Photomicrographs were performed on an Olympus Provis AX-70 microscope (Olympus Corporation, Tokyo, Japan) fitted with a DXM 1200 digital camera (Nikon Corporation, Tokyo, Japan).

Statistical analysis

Results are expressed as the mean ± standard error. The data were compared by analysis of variance; significant differences in the means were compared with the Newman-Keuls test. Values were analyzed using the statistical package Statistica, version 8.0 (Statsoft, Inc., Tulsa, OK, USA).

Results

Histological findings

The livers of the CS group exhibited normal cell structure. In the RS group, the hepatocytes were swollen and enlarged (ballooned cells) 7 days following irradiation, due to marked hydropic degeneration, mainly in the mid-zonal and periportal areas. Hyaline inclusions (Mallory bodies) were observed within the ballooning hepatocytes. Occasional inflammatory cell infiltration (mainly lymphocytes) was observed in the portal triads of the RS group. The RQ group exhibited a reduction in hepatic pathological changes compared with the RS group, and mild hydropic change was observed in periportal hepatocytes. No significant hepatic pathological changes were observed in the CQ group compared with solvent-supplemented controls.

The hepatocellular degeneration in irradiated animals was more diffuse at 30 days post-irradiation, and some small portal infiltrates consisting mainly of lymphocytes were identified. Hepatocyte cytoplasm appeared diffusely vacuolized with a central nucleus, which is a feature compatible with fluid metabolism alteration (Fig. 1). Mitotic activity of hepatocytes and a high proportion of binucleate cells were evident. No differences were identified between RQ animals and the RS group. Thirty days following irradiation, untreated animals also displayed discrete portal infiltration with lymphocytes and macrophages. Hepatocytes, mainly from periportal areas, exhibited dense cytoplasmic inclusions, which may have been protein-based (hyaline droplets or Mallory bodies).

Figure 1

Liver parenchyma of (A) CS, (B) CQ, (C) RS (exhibiting diffuse cytoplasmic vacuolation. Arrow indicates the location of a Mallory body, magnification ×200) and (D) RQ rat at 7 days post-irradiation, and a (E) RS and (F) RQ rat at 30 days post-irradiation. CS, control solvent-supplemented; CQ, control quercetin-supplemented; RS, irradiated solvent-supplemented; RQ, irradiated quercetin-supplemented.

Oxidative stress markers

The cytoplasmic concentration of thiobarbituric acid reactive substance (TBARS), a marker for lipid peroxidation, was significantly increased in the RS group compared with the CS group, at 7 and 30 days post-irradiation (39.89 and 4.21%, respectively). In RQ animals, the cytoplasmic concentration of TBARS increased to a lesser degree than in RS rats (Fig. 2).

Figure 2

Lipid peroxidation in liver extracts obtained at 7 or 30 days post-irradiation. Data are presented as the mean value ± standard error, n=8 in each group. *P<0.05 vs. CS, #P<0.05 vs. RS.

Expression of antioxidant enzymes (CAT, Cu/ZN-SOD, NQO1)

The expression of antioxidant enzymes was quantified by the measurement of protein levels using western blotting. CAT expression at 7 days post-irradiation was increased in irradiated animals, supplemented or unsupplemented with quercetin (47 and 53%, respectively). No changes were observed in CAT enzyme expression at 30 days post-irradiation between any of the experimental groups. An increased expression level of Cu/Zn-SOD was observed in all irradiated animals (RS and RQ) at 7 and 30 days post-irradiation. This increase was significantly reduced by quercetin supplementation, but Cu/Zn-SOD expression did not return to control levels (Fig. 3). The expression of the NQO1 enzyme increased in all irradiated animals at 7 and 30 days post-irradiation with or without quercetin supplementation (Fig. 3).

Figure 3

Protein expression of Cu/Zn-SOD, CAT and NQO1 in livers from the different experimental groups at 7 and 30 days following irradiation. At the top, representative Western blot photographs are shown. Data are presented as the mean value ± standard error, n=8 in each group. GADPH was used as loading control. *P<0.05 vs. CS, #P<0.05 vs. RS. Cu/Zn-SOD, copper/zinc superoxide dismutase; CAT, catalase; NQO1, NAD(P)H: quinone oxidoreductase 1; CS, control solvent-supplemented; CQ, control quercetin-supplemented; RS, irradiated solvent-supplemented; RQ, irradiated quercetin-supplemented.

Expression of transcription factor Nrf2 and protein Keap1

As presented in Fig. 4, irradiation in quercetin-supplemented and unsupplemented animals induced a significant increase (59 and 70%, respectively) of nuclear expression levels of Nrf2 at 7 days post-irradiation. This activation was less marked at 30 days post-irradiation (Fig. 4, upper panel). By contrast, cytoplasmic Nrf2 expression levels remained unchanged throughout the experiment, irrespective of quercetin supplementation (Fig. 4, middle panel). The expression of Keap1 protein in the liver cytoplasmic fraction significantly increased in all irradiated animals (RQ and RS, vs. CS) at 7 and 30 days post-irradiation (Fig. 4). This increase in Keap1 protein expression level was reduced in RQ animals at 30 days, to a level that was not significantly higher than the level of the CS group.

Figure 4

Protein expression of Nrf2 in cytoplasmic (c-Nrf2) and nuclear (n-Nrf2) compartments, and cytoplasmic Keap1 in livers from the four experimental groups at 7 and 30 days post-irradiation. At the top, representative western blot photographs are presented. Data are expressed as the mean value ± standard error, n=8 in each group. GADPH was used as loading control. *P<0.05 vs. CS, #P<0.05 vs. RS. Nrf2, nuclear factor (erythroid-derived 2)-like 2; Keap1, Kelch-like ECH-associated protein 1; CS, control solvent-supplemented; CQ, control quercetin-supplemented; RS, irradiated solvent-supplemented; RQ, irradiated quercetin-supplemented.

Discussion

Experimental quercetin supplementation has been used to counteract oxidative stress in a number of forms, including dissolved in water (14), ethanol (15) or propylenglycol (12), or food-supplemented (12). Quercetin has been used as pre-treatment to radiation in mice (16) and other flavonoids have been tested both prior to and following irradiation (17). The present study has demonstrated the radiomitigative effects of quercetin when administered for four days prior to and six days following whole-body X-irradiation.

Hepatic injury induced by radiation is characterized by the loss of parenchymal hepatocytes and the distortion of the lobular architecture, which is accompanied by periportal fibrosis (18). Previous studies on human liver have indicated that the reaction of the liver to irradiation is largely dependent upon parameters such as the type of irradiation, dose, dose rate, fractionation schedule and irradiated volume, and the liver function is not normally compromised unless radiation doses >35 Gy are used (19). The sensitivity of hepatocytes to ionizing radiation has been observed to be similar in human and rat liver tissues (20). The results of the present study suggest a marked hydropic degeneration at 7 or 30 days post-irradiation (6 Gy), which is most likely due to an intra-cytoplasmic accumulation of fluid as a result of the disturbed integrity of the cell membrane. Mallory bodies are accepted to represent degenerate cytoskeleton in damaged hepatocytes and are a consequence of cellular injury (21).

Quercetin supplementation may protect cells from the damage induced by ionizing radiation, since the data of the present study indicated that hydropic change was less extended and limited to periportal areas in quercetin-supplemented rats, compared with controls.

Ionizing radiation is established to induce oxidative stress through the generation of reactive oxygen species, resulting in an imbalance in the pro-oxidant/antioxidant status of the cells (22–24). Data of the current study indicate an apparent increase in lipid peroxidation at 7 days post-irradiation. The presence of oxidative stress in the experimental model was confirmed by increased levels of TBARS in the liver in addition to the increase in the expression of the enzymatic antioxidant system. In the current results, lipid peroxidation reduced 30 days following irradiation to levels half of those observed 7 days following irradiation, but were still significantly higher than the non-irradiated controls. This is consistent with previous reports of decreased oxidative stress in rats 68 days after 8 Gy irradiation compared with 10 days post-irradiation (25). The present results indicate that quercetin may prevent oxidative stress, reducing the increase in lipid peroxidation markers and maintaining the expression of antioxidant enzymes.

Similar to previous reports (26), Nrf2 expression levels in the nuclear fraction were increased in response to X-irradiation, confirming the important role of this nuclear factor in the antioxidant cell response. In contrast, no significant effects were observed following analysis of cytoplasmic Nrf2 expression levels. The present study also demonstrated that X-irradiation is able to activate Nrf2 in order to increase ARE-dependent gene expression 7 days following irradiation, but activated it to a lesser extent at 30 days post-irradiation. An accompanying increase in the expression of several antioxidant enzymes (CAT, Cu/Zn-SOD, NQO1) was also observed. Nrf2 expression levels were significantly reduced in the RQ animals compared with the RS group. These results may be interpreted as follows: By decreasing the levels of free radicals following quercetin supplementation, the activation of Nrf2 is reduced in accordance with the presently lower oxidation status. This idea is reinforced by the findings of McDonald et al (27) who indicated activation of Nrf2 following single doses of ionizing radiation from 2–8 Gy in breast cancer cells in a dose-dependent manner, but only following a delay of 5 days. As a result of the exogenous antioxidants glutathione and PEG-SOD (but not PEG-CAT) being administered post-irradiation, they demonstrated partially reduced ARE reporter activity after 5 days. This is also consistent with the finding of the present study, which indicated that Cu/Zn-SOD expression levels, but not those of CAT or NQO1, were reduced in RQ rats. However, other authors have reported increased Nrf2 expression levels following antioxidant administration. Liu et al (28) did not observe increased Nrf2 levels in mouse brain after 12 h of a single 4 Gy radiation dose, but did observe an increase with increasing concentrations of melatonin (1–10 mg/kg). Similarly, following dimethylnitrosamine-induced ROS increase, melatonin (50 mg/kg) administration over 14 days was able to double the nuclear levels of Nrf2 (29).

It is accepted that Keap1 is a protein involved in detecting oxidative stress via oxidative modification of distinct cysteine residues, leading to conformational changes that allow for the release of Nrf2, but Nrf2 itself may behave as a redox sensor. As the concentration of oxidants becomes higher, more Nrf2 proteins translocate into the nucleus at a higher speed. This graded nuclear translocation of Nrf2 indicates that Nrf2 can transmit the presence of oxidative stress and also the intensity of oxidative stress (30). An autoregulation interplay cycle has been reported between Nrf2 and Keap1, in that the increase in Nrf2 expression levels may induce the inducing activity of the Keap1 gene by binding to an ARE in the reverse strand of the proximal promoter of the Keap1 gene (31). This positive feedback may aid in explaining the parallel increases in nuclear Nrf2 and cytoplasmic Keap1 protein expression observed at 7 days post-irradiation, in addition to the reduced levels observed as a result of quercetin supplementation.

The Cu/Zn-SOD gene promoter contains an antioxidant responsive element (32). The transcription of the Cu/Zn-SOD gene has been reported to be upregulated in human HepG2 hepatoma cells following dioxin treatment used to induce ROS production and the activation of Nrf2 signalling (33), and also after irradiation in human oral cancer following preoperative radiation therapy (34) and human prostate cancer cells (35). In the results of the current study, the observed increase in Cu/Zn-SOD expression levels following whole-body irradiation is consistent with the activation of Nrf2 by increased oxidative stress. Quercetin supplementation reduced Cu/Zn-SOD expression levels, but they remained at a significantly higher level than non-irradiated controls, possibly as a consequence of the reduction in Nrf2 expression levels.

The current study indicated that NQO1 expression was significantly increased at 7 days post-irradiation, and it remained unchanged following quercetin supplementation, while Nrf2 expression levels were significantly reduced in the RQ group. In order to explain these findings it may be important to consider the free radical-scavenging activity of quercetin, and that it produces oxidized derivatives such as quercetin ortho-quinone/quinone methide, which is a substrate that interacts with NQO1 (36). The fact that NQO1 expression was not altered in RQ rats may be attributed to the additional need for NQO1 to inactivate the potentially harmful oxidation products derived from quercetin antioxidant activity. Further research is required to clarify the dynamics of quercetin-derived adducts and their role in the antioxidant regulatory pathways.

The distinct changes in antioxidant enzyme expression observed in the present study can be interpreted by considering that ionizing radiation induces multiple molecular changes in the cells, depending on the dose and the time of testing. Transcription factors such as AP-1 and nuclear factor (NF)-κB are activated only 24 h after irradiation (37), while MnSOD is simultaneously induced through the NF-κB pathway. It has also been reported that human lymphoblasts exposed at 3 Gy display increased levels of CAT and glutathione-peroxidase, but no other enzymes, at 20 h post-irradiation, suggesting that a low dose of radiation induces an increase in the expression of antioxidant enzymes as a radiomodifying response (38). Similarly, McDonald et al (27) demonstrated increased activation of Nrf2 after 5 days exposure of several cell lines to 8 Gy irradiation.

Quercetin has been successfully tested as an antioxidant in several in vitro studies using cell cultures (16,39,40), but its in vivo activity has been questioned. Studying vitamin E-deficient rats supplemented with vitamin E or a variety of flavonoids, including quercetin, Duthie et al (41) concluded that in vivo supplementation with these antioxidant compounds (100 mg/kg diet) is ineffective in restoring lipid peroxidation indices in plasma and liver. However, another study has indicated that serum malondialdehyde levels are inversely correlated to the oral daily quercetin dose (0.01–1.00 g/kg body weight) after 22 days of treatment in otherwise normal Wistar rats (42); and this is in line with the results from the current study on lipid peroxidation.

Overexpression of Nrf2 can result in enhanced resistance of tumoral cells to chemotherapeutic agents, while downregulation of Nrf2 has been translated into more susceptibility to these drugs (43). These findings suggest that cancer cells can protect themselves from the stress-inducing conditions of the tumoral environment: An active Nrf2 pathway may promote a favorable redox balance and upregulate antioxidant gene products in order to enhance their survival; by contrast, normal cells do not have such high metabolic requirements and Nrf2 levels are not expected to be elevated to such a level. Supporting this view, in HepG2 cells incubated with 0–40 μM quercetin, this flavonoid enhanced the steady-state level of Nrf2 and also reduced the steady-state level of Keap1 through 26S proteasome-independent degradation (1). The study also concluded that quercetin is able to increase the protein level of Nrf2 and simultaneously inhibit its ubiquitination, while Keap1 expression is reduced. While these effects have been observed in cell cultures without additional treatment, it has been recently reported that the combination of quercetin plus X-irradiation can significantly increase the tumoral radiosensitivity in vitro and in vivo (44). The data from the current study have demonstrated that quercetin in vivo supplementation influences the antioxidant system by reducing lipid peroxidation and modifying the activation of Nrf2 and various antioxidant enzymes. By administering quercetin to X-irradiated animals, its antioxidant status was improved; the present study demonstrated that the oxidative stress-associated increase in Nrf2 expression levels in X-irradiated rats was diminished following quercetin supplementation. This approach could be utilized to avoid favoring cancer cell survival (by hindering the increase in Nrf2 expression levels), so quercetin may produce effects that reduce the oxidative stress-associated increase in Nrf2 expression levels, which may be beneficial in the prevention of cancer growth.

Acknowledgements

The authors are grateful for the financial support provided by Fundación Mapfre, and to Dra. María Teresa Ribas Ariño for her helpful assistance in histopathological interpretation.

Abbreviations:

ARE

antioxidant response element

CAT

catalase

Cu/ZnSOD

copper/zinc superoxide dismutase

EpRE

electrophile response element

Keap1

Kelch-like ECH-associated protein 1

MnSOD

manganese superoxide dismutase

NQO1

NAD(P)H: quinone oxidoreductase 1

Nrf2

nuclear factor (erythroid-derived 2)-like 2

PEG-CAT

polyethylene glycol-conjugated catalase

PEG-SOD

polyethylene glycol-conjugated superoxide dismutase

QQ

quercetin ortho-quinone/quinone methide

TBARS

thiobarbituric acid reactive substance

References

1 

Tanigawa S, Fujii M and Hou D: Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Rad Biol Med. 42:1690–1703. 2007. View Article : Google Scholar : PubMed/NCBI

2 

Aleksunes LM and Manautou JE: Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol Pathol. 35:459–473. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Middleton EJ, Kandaswami C and Theoharides T: The effects of plants flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 52:673–751. 2000.PubMed/NCBI

4 

González-Gallego J, García-Mediavilla MV, Sánchez-Campos S and Tuñón MJ: Fruit polyphenols, immunity and inflammation. Br J Nutr. 104:S15–S27. 2010.PubMed/NCBI

5 

Hosseinimehr SJ: Trends in the development of radioprotective agents. Drug Discov Today. 12:794–805. 2007. View Article : Google Scholar

6 

Otsuka K, Koana T, Tauchi H and Sakai K: Activation of antioxidative enzymes induced by low-dose-rate whole-body gamma irradiation: adaptive response in terms of initial DNA damage. Radiat Res. 166:474–478. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Okunieff P, Swarts S, Keng P, et al: Antioxidants reduce consequences of radiation exposure. Adv Exp Med Biol. 614:165–178. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Marnett LJ: Oxy radicals, lipid peroxidation and DNA damage. Toxicology. 181–182:219–222. 2002.PubMed/NCBI

9 

Wallace DC: The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene. 354:169–180. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Nwokocha CR, Nwokocha M, Mounmbegna P, et al: Proteins and liver function changes in rats following cumulative total body irradiations. West Indian Med J. 61:773–777. 2012.PubMed/NCBI

11 

Citrin D, Cotrim AP, Hyodo F, et al: Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist. 15:360–371. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Kawai Y, Saito S, Nishikawa T, et al: Different profiles of quercetin metabolites in rat plasma: comparison of two administration methods. Biosci Biotechnol Biochem. 73:517–523. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Willis ED: Evaluation of lipid peroxidation in lipids and biological membranes. Biochemical Toxicology: A Practical Approach. Snell KB and Mullock B: IRL Press; Oxford: pp. 407–420. 1987

14 

Jung JH, Kang JI and Kim HS: Effect of quercetin on impaired immune function in mice exposed to irradiation. Nutr Res Pract. 6:301–307. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Kanter M, Aktas C and Erboga M: Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis. Food Chem Toxicol. 50:719–25. 2012. View Article : Google Scholar

16 

Benkovic V, Knezevic AH, Dikic D, et al: Radioprotective effects of quercetin and ethanolic extract of propolis in gamma-irradiated mice. Arh Hig Rada Toksikol. 60:129–138. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Sezer A, Usta U, Kozak Z and Yagci MA: The effect of a flavonoid fractions diosmin + hesperidin on radiation-induced acute proctitis in a rat model. J Cancer Res Ther. 7:152–156. 2011. View Article : Google Scholar : PubMed/NCBI

18 

An JH, Kim J and Seong J: Redox signaling by ionizing radiation in mouse liver. Ann NY Acad Sci. 1030:86–94. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Cromheecke M, Konings AW, Szabo BG and Hoekstra HJ: Liver tissue tolerance for irradiation: experimental and clinical investigations. Hepatogastroenterology. 47:1732–4170. 2000.PubMed/NCBI

20 

Alati T, Van Cleef M, Strom SC and Jirtle RL: Radiation sensitivity of adult human parenchymal hepatocytes. Radiat Res. 115:152–160. 1988. View Article : Google Scholar : PubMed/NCBI

21 

Pei RJ, Danbara N, Tsujita-Kyutoku M, et al: Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies. Med Electron Microsc. 37:114–118. 2004.PubMed/NCBI

22 

Bhosle SM, Huilgol NG and Mishra KP: Enhancement of radiation-induced oxidative stress and cytotoxicity in tumor cells by ellagic acid. Clin Chim Acta. 359:89–100. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Karran P: DNA double strand break repair in mammalian cells. Curr Opin Genetics Dev. 10:144–150. 2000. View Article : Google Scholar : PubMed/NCBI

24 

Andrade ER, Cruz IB, Andrade VV, et al: Evaluation of the potential protective effects of ad libitum black grape juice against liver oxidative damage in whole-body acute X-irradiated rats. Food Chem Toxicol. 49:1026–1032. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Meydan D, Gursel B, Bilgici B, Can B and Ozbek N: Protective effect of lycopene against radiation-induced hepatic toxicity in rats. J Int Med Res. 39:1239–1252. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Tsukimoto M, Tamaishi N, Homma T and Kojima S: Low-dose gamma-ray irradiation induced translocation of Nrf2 into nuclear in mouse macrophague RAW264.7. J Radiat Res. 51:349–353. 2010. View Article : Google Scholar : PubMed/NCBI

27 

McDonald JT, Kim K, Norris AJ, et al: Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res. 70:8886–8895. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Liu Y, Zhang L, Zhang H, et al: Exogenous melatonin modulates apoptosis in the mouse brain induced by high-LET carbon ion irradiation. J Pineal Res. 52:47–56. 2012. View Article : Google Scholar : PubMed/NCBI

29 

Jung KH, Hong SW, Zheng HM, Lee DH and Hong SS: Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model. J Pineal Res. 47:173–183. 2009. View Article : Google Scholar

30 

Li W, Khor TO, Xu C, et al: Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem Pharmacol. 76:1485–1489. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Lee OH, Jain AK, Papusha V and Jaiswal AK: An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J Biol Chem. 282:36412–36420. 2007. View Article : Google Scholar : PubMed/NCBI

32 

Milani P, Gagliardi S, Cova E and Cereda C: SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS. Neurol Res Int. 2011:4584272011.PubMed/NCBI

33 

Park EY and Rho HM: The transcriptional activation of the human copper/zinc superoxide dismutase gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin through two different regulator sites, the antioxidant responsive element and xenobiotic responsive element. Mol Cell Biochem. 240:47–55. 2002. View Article : Google Scholar

34 

Terakado N, Shintani S, Nakahara Y, et al: Expression of Cu/Zn-SOD, Mn-SOD and GST-pi in oral cancer treated with preoperative radiation therapy. Oncol Rep. 7:1113–1117. 2000.PubMed/NCBI

35 

Vucic V, Isenovic ER, Adzic M, Ruzdijic S and Radojcic MB: Effects of gamma-radiation on cell growth, cycle arrest, death, and superoxide dismutase expression by DU 145 human prostate cancer cells. Braz J Med Biol Res. 39:227–236. 2006. View Article : Google Scholar : PubMed/NCBI

36 

Boots AW, Bast A and Haenen GR: No role of DT-diaphorase (NQO1) in the protection against oxidized quercetin. FEBS Lett. 579:677–82. 2005. View Article : Google Scholar : PubMed/NCBI

37 

Orlowski RZ and Baldwin AS Jr: NF-kappaB as a therapeutic target in cancer. Trends Mol Med. 8:385–389. 2002. View Article : Google Scholar : PubMed/NCBI

38 

Bravard A, Luccioni C, Moustacchi E and Rigaud O: Contribution of antioxidant enzymes to the adaptative response to ionizing radiation of human lymphoblasts. Int J Radiat Biol. 75:639–645. 1999. View Article : Google Scholar : PubMed/NCBI

39 

Crespo I, Garcia-Mediavilla MV, Almar M, et al: Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells. Food Chem Toxicol. 46:1555–1569. 2008. View Article : Google Scholar

40 

Kook D, Wolf AH, Yu AL, et al: The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci. 49:1712–1720. 2008. View Article : Google Scholar : PubMed/NCBI

41 

Duthie G and Morrice P: Antioxidant capacity of flavonoids in hepatic microsomes is not reflected by antioxidant effects in vivo. Oxid Med Cell Longev. 2012:1651272012.PubMed/NCBI

42 

Nakamura Y, Ishimitsu S and Tonogai Y: Effects of quercetin and rutin on serum and hepatic lipid concentrations, fecal steroid excretion and serum antioxidant properties. J Health Sci. 46:229–240. 2000. View Article : Google Scholar

43 

Wang XJ, Sun Z, Villeneuve NF, et al: Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis. 29:1235–1243. 2008. View Article : Google Scholar : PubMed/NCBI

44 

Lin C, Yu Y, Zhao HG, et al: Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo. Radiother Oncol. 104:395–400. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Marina R, González P, Ferreras MC, Costilla S and Barrio JP: Hepatic Nrf2 expression is altered by quercetin supplementation in X‑irradiated rats. Mol Med Rep 11: 539-546, 2015.
APA
Marina, R., González, P., Ferreras, M.C., Costilla, S., & Barrio, J. (2015). Hepatic Nrf2 expression is altered by quercetin supplementation in X‑irradiated rats. Molecular Medicine Reports, 11, 539-546. https://doi.org/10.3892/mmr.2014.2741
MLA
Marina, R., González, P., Ferreras, M. C., Costilla, S., Barrio, J."Hepatic Nrf2 expression is altered by quercetin supplementation in X‑irradiated rats". Molecular Medicine Reports 11.1 (2015): 539-546.
Chicago
Marina, R., González, P., Ferreras, M. C., Costilla, S., Barrio, J."Hepatic Nrf2 expression is altered by quercetin supplementation in X‑irradiated rats". Molecular Medicine Reports 11, no. 1 (2015): 539-546. https://doi.org/10.3892/mmr.2014.2741
Copy and paste a formatted citation
x
Spandidos Publications style
Marina R, González P, Ferreras MC, Costilla S and Barrio JP: Hepatic Nrf2 expression is altered by quercetin supplementation in X‑irradiated rats. Mol Med Rep 11: 539-546, 2015.
APA
Marina, R., González, P., Ferreras, M.C., Costilla, S., & Barrio, J. (2015). Hepatic Nrf2 expression is altered by quercetin supplementation in X‑irradiated rats. Molecular Medicine Reports, 11, 539-546. https://doi.org/10.3892/mmr.2014.2741
MLA
Marina, R., González, P., Ferreras, M. C., Costilla, S., Barrio, J."Hepatic Nrf2 expression is altered by quercetin supplementation in X‑irradiated rats". Molecular Medicine Reports 11.1 (2015): 539-546.
Chicago
Marina, R., González, P., Ferreras, M. C., Costilla, S., Barrio, J."Hepatic Nrf2 expression is altered by quercetin supplementation in X‑irradiated rats". Molecular Medicine Reports 11, no. 1 (2015): 539-546. https://doi.org/10.3892/mmr.2014.2741
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team